updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
Published 1 year ago • 496 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
2:21
clinical updates on the use of momelotinib for mpns
-
1:45
momelotinib vs soc in patients with mf and anemia: an analysis from the simplify-2 trial
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
2:44
myelofibrosis: jenson shares his experience
-
1:44
momelotinib: a promising agent in mf
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
4:25
update on momelotinib for myelofibrosis
-
1:40
momelotinib for the treatment of myelofibrosis
-
1:30
mosunetuzumab in the treatment of hcl: a case study
-
1:24
updated results from the momentum study assessing the efficacy of momelotinib in mf
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
3:02
latest updates on momelotinib: safety, durability of response & survival benefit
-
4:48
an insight into the management of cytopenias in mf
-
2:54
unmet needs in myelofibrosis and future outlooks
-
4:15
the latest data on momelotinib for mpns
-
3:44
phase ii study update of navtemadlin in patients with myelofibrosis r/r to ruxolitinib